About Eurogentec
Eurogentec is a company based in Seraing (Belgium) founded in 1985 was acquired by Kaneka in June 2010. The company has 426 employees as of March 31, 2023. Eurogentec has completed 1 acquisition, including AnaSpec. Eurogentec offers products and services including Oligos, PCR Kits, Antibodies, and Peptides. Eurogentec operates in a competitive market with competitors including Nephron Pharmaceuticals, Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm and Suanfarma, among others.
- Headquarter Seraing, Belgium
- Employees 426 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kaneka Eurogentec
-
Annual Revenue
$113.57 M (USD)21as on Mar 31, 2023
-
Net Profit
$14.39 M (USD)24as on Mar 31, 2023
-
EBITDA
$27.36 M (USD)26as on Mar 31, 2023
-
Latest Funding Round
$51.55 K (USD), Grant
Sep 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
426
as on Mar 31, 2023
- Investments & Acquisitions
-
Acquired by
Kaneka
(Jun 15, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eurogentec
Eurogentec offers a comprehensive portfolio of products and services, including Oligos, PCR Kits, Antibodies, and Peptides.
Custom synthesized oligonucleotides for research and diagnostics applications.
Kits for quantitative PCR assays in gene analysis.
Custom polyclonal and monoclonal antibodies for protein detection.
Synthesized peptides for research and therapeutic uses.
Funding Insights of Eurogentec
Investors in Eurogentec
Eurogentec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Kaneka.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Chemical products are produced for diverse industrial applications.
|
Locked | Locked | Locked |
Investor details for Eurogentec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eurogentec
Eurogentec has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AnaSpec.
Investment portfolio details for Eurogentec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Premier provider of reagents and services for research, HTP screening, and drug discovery. Services include peptide/oligo synthesis, Ab prod., and assay dev.
|
Locked | Locked | 1993 | Locked |
Complete acquisition details for Eurogentec
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Eurogentec
Detailed financials for Eurogentec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eurogentec Comparisons
Peer comparison for Eurogentec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eurogentec
Eurogentec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nephron Pharmaceuticals, Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm and Suanfarma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| Locked | Locked | Locked |
Biotech company developing personalized medicines for cardiovascular diseases
|
Detailed competitors of Eurogentec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eurogentec
Complete news archive for Eurogentec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eurogentec
Eurogentec was founded in 1985 and raised its 1st funding round 30 years after it was founded.
Eurogentec is headquartered in Seraing, Belgium. It is registered at Seraing, Liege, Belgium.
As of Mar 31, 2023, the latest employee count at Eurogentec is 426.
Annual revenue of Eurogentec is $113.57M as on Mar 31, 2023.
Eurogentec S.A., is a leading global supplier of innovative reagents, kits, specialty products and custom services. It has three inter-related business units (BU). Life Science Research BU is specialized in innovative solutions in Genomics and Proteomics, through which it supplies a wide range of reagents, kits and consumables for Life Science applications such as Custom Oligonucleotides, high performance PCRqPCR Kits Reagents, catalogue dyes, peptides antibodies. It also offers custom synthesis of petides and antibodies. The Diagnostic Services BU provides technical and project support for contract manufacturing of GMP oligonucleotides and Taq DNA polymerases. The GMP BioManufacturing BU is a US FDA inspected full-service Contract Manufacturing Organization (CMO). It offers expertise in technology transfer, process development, scale-up and cGMP manufacturing of proteins, protein conjugates, plasmid DNA and bacterial vaccines for pre-clinical, clinical and commercial uses. They claim to be experts in microbial cell lines (E.coli, P. pastoris etc.,) and also to have developed over 100 different GMP biopharmaceuticals since 1994. In 2009, Eurogentec acquired AnaSpec, a provider of integrated proteomics solutions for life science research and diagnostics. In 2010, Eurogentec became part of Kaneka Corporation, Osaka, Japan, a chemical company active in polymers, fermentation, biotechnology and electronics, as well as other fields.
Eurogentec's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
Eurogentec offers Oligos, PCR Kits, Antibodies, and Peptides.
Eurogentec has made 1 acquisition, including AnaSpec.
Eurogentec has 2 investors. Key investors include European Union, and Kaneka.